|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of human caspase-2 in complex with acetyl-leu-asp- glu-ser-asp-cho
|
|
Structure:
|
 |
Caspase-2. Chain: a, c. Fragment: subunit p18, sequence database residues 151-316. Synonym: casp-2, ich-1 protease, ich- 1l/1s. Engineered: yes. Caspase-2. Chain: b, d. Fragment: subunit p12, sequence database residues 331-435. Synonym: casp-2, ich-1 protease, ich- 1l/1s.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: casp2 or ich1. Expressed in: escherichia coli. Expression_system_taxid: 562. Synthetic: yes. Saccharomyces cerevisiae (baker's yeast). Organism_taxid: 559292.
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
1.65Å
|
R-factor:
|
0.189
|
R-free:
|
0.213
|
|
|
Authors:
|
 |
A.Schweizer,C.Briand,M.G.Grutter
|
Key ref:
|
 |
A.Schweizer
et al.
(2003).
Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway.
J Biol Chem,
278,
42441-42447.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
09-Jul-03
|
Release date:
|
26-Aug-03
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
278:42441-42447
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway.
|
|
A.Schweizer,
C.Briand,
M.G.Grutter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The cell death protease caspase-2 has recently been recognized as the most
apical caspase in the apoptotic cascade ignited during cell stress signaling.
Cytotoxic stress, such as that caused by cancer therapies, leads to activation
of caspase-2, which acts as a direct effector of the mitochondrion-dependent
apoptotic pathway resulting in programmed cell death. Here we report the x-ray
structure of caspase-2 in complex with the inhibitor
acetyl-Leu-Asp-Glu-Ser-Asp-aldehyde at 1.65-A resolution. Compared with other
caspases, significant structural differences prevail in the active site region
and the dimer interface. The structure reveals the hydrophobic properties of the
S5 specificity pocket, which is unique to caspase-2, and provides the details of
the inhibitor-protein interactions in subsites S1-S4. These features form the
basis of caspase-2 specificity and allow the design of caspase-2-directed
ligands for medical and analytical use. Another unique feature of caspase-2 is a
disulfide bridge at the dimer interface, which covalently links the two
monomers. Consistent with this finding, caspase-2 exists as a (p19/p12)2 dimer
in solution, even in the absence of substrates or inhibitors. The intersubunit
disulfide bridge stabilizes the dimeric form of caspase-2, whereas all other
long prodomain caspases exist as monomers in solution, and dimer formation is
driven by ligand binding. Therefore, the central disulfide bridge appears to
represent a novel way of dimer stabilization in caspases.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
FIG. 2. Comparison of the enzyme inhibitor interaction
network of caspase-2 and caspase-3. Schematic drawing of the
caspase-2 Ac-LDESD-cho inhibitor complex (a) and the caspase-3
Ac-DEVD-cho inhibitor complex (b) (1PAU [PDB]
; 37) with hydrogen bond interactions drawn as dashed lines
(length: 2.6-3.4 Å). The diagram was produced by ChemDraw.
|
 |
Figure 3.
FIG. 3. Binding pockets of caspase-2, caspase-3, and
caspase-7. Comparison of the substrate binding region of
caspase-2/Ac-LDESD-cho (a) with caspase-3/Ac-DEVD-cho (b) (1PAU
[PDB]
; 37) and caspase-7/Ac-DEVD-cho (c) (1F1J [PDB]
; 35) using molecular surface representations. The inhibitors
are drawn as stick models, the P5 Leu is colored in green as
well as the N-terminal acetyl groups of the tetrapeptidic
inhibitors. Surfaces are colored according to their
electrostatic potential: positive and negative regions are
indicated in blue and red, respectively. The figures were
generated using the program GRASP (48).
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2003,
278,
42441-42447)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.J.Leyva,
F.Degiacomo,
L.S.Kaltenbach,
J.Holcomb,
N.Zhang,
J.Gafni,
H.Park,
D.C.Lo,
G.S.Salvesen,
L.M.Ellerby,
and
J.A.Ellman
(2010).
Identification and evaluation of small molecule pan-caspase inhibitors in Huntington's disease models.
|
| |
Chem Biol,
17,
1189-1200.
|
 |
|
|
|
|
 |
B.Fang,
G.Fu,
J.Agniswamy,
R.W.Harrison,
and
I.T.Weber
(2009).
Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling.
|
| |
Apoptosis,
14,
741-752.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.Krumschnabel,
B.Sohm,
F.Bock,
C.Manzl,
and
A.Villunger
(2009).
The enigma of caspase-2: the laymen's view.
|
| |
Cell Death Differ,
16,
195-207.
|
 |
|
|
|
|
 |
M.Madesh,
W.X.Zong,
B.J.Hawkins,
S.Ramasamy,
T.Venkatachalam,
P.Mukhopadhyay,
P.J.Doonan,
K.M.Irrinki,
M.Rajesh,
P.Pacher,
and
C.B.Thompson
(2009).
Execution of superoxide-induced cell death by the proapoptotic Bcl-2-related proteins Bid and Bak.
|
| |
Mol Cell Biol,
29,
3099-3112.
|
 |
|
|
|
|
 |
N.Keller,
J.Mares,
O.Zerbe,
and
M.G.Grütter
(2009).
Structural and biochemical studies on procaspase-8: new insights on initiator caspase activation.
|
| |
Structure,
17,
438-448.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
T.Kitevska,
D.M.Spencer,
and
C.J.Hawkins
(2009).
Caspase-2: controversial killer or checkpoint controller?
|
| |
Apoptosis,
14,
829-848.
|
 |
|
|
|
|
 |
G.Fu,
A.A.Chumanevich,
J.Agniswamy,
B.Fang,
R.W.Harrison,
and
I.T.Weber
(2008).
Structural basis for executioner caspase recognition of P5 position in substrates.
|
| |
Apoptosis,
13,
1291-1302.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Baptiste-Okoh,
A.M.Barsotti,
and
C.Prives
(2008).
A role for caspase 2 and PIDD in the process of p53-mediated apoptosis.
|
| |
Proc Natl Acad Sci U S A,
105,
1937-1942.
|
 |
|
|
|
|
 |
A.Schweizer,
H.Roschitzki-Voser,
P.Amstutz,
C.Briand,
M.Gulotti-Georgieva,
E.Prenosil,
H.K.Binz,
G.Capitani,
A.Baici,
A.Plückthun,
and
M.G.Grütter
(2007).
Inhibition of caspase-2 by a designed ankyrin repeat protein: specificity, structure, and inhibition mechanism.
|
| |
Structure,
15,
625-636.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
A.Yoshimori,
J.Sakai,
S.Sunaga,
T.Kobayashi,
S.Takahashi,
N.Okita,
R.Takasawa,
and
S.Tanuma
(2007).
Structural and functional definition of the specificity of a novel caspase-3 inhibitor, Ac-DNLD-CHO.
|
| |
BMC Pharmacol,
7,
8.
|
 |
|
|
|
|
 |
D.Chauvier,
S.Ankri,
C.Charriaut-Marlangue,
R.Casimir,
and
E.Jacotot
(2007).
Broad-spectrum caspase inhibitors: from myth to reality?
|
| |
Cell Death Differ,
14,
387-391.
|
 |
|
|
|
|
 |
J.Agniswamy,
B.Fang,
and
I.T.Weber
(2007).
Plasticity of S2-S4 specificity pockets of executioner caspase-7 revealed by structural and kinetic analysis.
|
| |
FEBS J,
274,
4752-4765.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.C.Timmer,
and
G.S.Salvesen
(2007).
Caspase substrates.
|
| |
Cell Death Differ,
14,
66-72.
|
 |
|
|
|
|
 |
Q.Bao,
and
Y.Shi
(2007).
Apoptosome: a platform for the activation of initiator caspases.
|
| |
Cell Death Differ,
14,
56-65.
|
 |
|
|
|
|
 |
S.R.Dunn,
W.S.Phillips,
J.W.Spatafora,
D.R.Green,
and
V.M.Weis
(2006).
Highly conserved caspase and Bcl-2 homologues from the sea anemone Aiptasia pallida: lower metazoans as models for the study of apoptosis evolution.
|
| |
J Mol Evol,
63,
95.
|
 |
|
|
|
|
 |
I.N.Lavrik,
A.Golks,
and
P.H.Krammer
(2005).
Caspases: pharmacological manipulation of cell death.
|
| |
J Clin Invest,
115,
2665-2672.
|
 |
|
|
|
|
 |
N.Yan,
and
Y.Shi
(2005).
Mechanisms of apoptosis through structural biology.
|
| |
Annu Rev Cell Dev Biol,
21,
35-56.
|
 |
|
|
|
|
 |
P.K.Ho,
and
C.J.Hawkins
(2005).
Mammalian initiator apoptotic caspases.
|
| |
FEBS J,
272,
5436-5453.
|
 |
|
|
|
|
 |
S.Kasibhatla,
K.A.Jessen,
S.Maliartchouk,
J.Y.Wang,
N.M.English,
J.Drewe,
L.Qiu,
S.P.Archer,
A.E.Ponce,
N.Sirisoma,
S.Jiang,
H.Z.Zhang,
K.R.Gehlsen,
S.X.Cai,
D.R.Green,
and
B.Tseng
(2005).
A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid.
|
| |
Proc Natl Acad Sci U S A,
102,
12095-12100.
|
 |
|
|
|
|
 |
J.A.Hardy,
J.Lam,
J.T.Nguyen,
T.O'Brien,
and
J.A.Wells
(2004).
Discovery of an allosteric site in the caspases.
|
| |
Proc Natl Acad Sci U S A,
101,
12461-12466.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.J.Riedl,
and
Y.Shi
(2004).
Molecular mechanisms of caspase regulation during apoptosis.
|
| |
Nat Rev Mol Cell Biol,
5,
897-907.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |